• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Improvement of neutralizing activity of anti-canine parvovirus antibodies through directed evolution.

Research Project

Project/Area Number 15580281
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Applied veterinary science
Research InstitutionNippon Institute for Biological Science

Principal Investigator

IWATA Akira  Nippon Institute for Biological Science, Research Dept., senior Scientific Stuff, 研究部, 主任研究員 (70193745)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Akira  Nippon Institute for Biological Science, Research Dept., Researcher, 研究部, 研究員 (40290986)
KANAI Tomoko  Nippon Institute for Biological Science, Research Dept., Researcher, 研究部, 研究員 (10300790)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2004: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2003: ¥1,600,000 (Direct Cost: ¥1,600,000)
Keywordsdog / parovovirus / treatment / neutralizing antibody / baculovirus / ScFv / caninized antibodies / 中和 / モノクローナル抗体
Research Abstract

(1)Characterization of monoclonal antibodies (mAb) to canine parvovirus (CPV)
Five mAbs (CPla - 5a) reacting to CPV has characterized through ELISA, agglutination activity of antigen-coated latex microspheres, Western blotting analysis, inhibitory activity to CPV's hemagglutination (HI), neutralizing activity against CPV (VN). The amino acid sequence of complementarity determining region (CDR) of each mAb was analyzed through cloning of cDNA of each V domain. The amino acid sequence of CDR was classified three types, and concomitantly, the biological activity of the mAbs correlated to the sequence.
(2)Expression of a canine immunoglobulin G (IgG) with recombinant baculoviruses.
Previously, we have cloned cDNA of canine IgG. In this study, we expressed IgG by baculovirus vector system. To express the canine IgG, two systems were prepared. The one was a recombinant baculovirus which has dual promoter and expresses both heavy and light chain at the same time. The another was co-infection wit … More h two recombinant baculoviruses which independently express light or heavy chain. The amount of secreted IgG in both system was the same, around 0.1 μg/mL. The recombinant IgG can be purified with protein A column, together with heavy chains. The IgG was reacted with anti-IgG2 antisera (Bethyl Lab. Inc.), so this molecule is IgG2 subclass.
(3)Construction of caninized antibody.
As homology of amino acid sequence of frame work region to canine IgG is highest among the mAbs, CP2a was selected as a donor of the CDR sequence. The caninized CP2a antibody was expressed by baculovirus system and characterized its binding property with donor CP2a by Western blotting. The caninized CP2a reacted with CPV proteins equally with CP2a, in the same peptide region (219-292) of VP2 proteins.
(4)Expression of single chain V fragment (scFv)
ScFv molecules was constructed with CP1a because of its highest HI and VN activity, and expressed in baculovirus system. The expression was confirmed with Western blotting using histidine hexamer tag, but the HI and VN activities were not observed. To adapt the directed evolution method to improve the property of the antibody, more basic data on structure-activity relationship of these antibodies were necessary to establish the platform. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (1 results)

All 2003

All Patent(Industrial Property Rights) (1 results)

  • [Patent(Industrial Property Rights)] イヌ化抗体の作製方法および使用2003

    • Inventor(s)
      岩田 晃他
    • Industrial Property Rights Holder
      (財)日本生物科学研究所
    • Industrial Property Number
      2003-175932
    • Filing Date
      2003-06-20
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi